Effect of Anti-Cd25 Antibody Daclizumab in the Inhibition of Inflammation and Stabilization of Disease Progression in Multiple Sclerosis

Archives of Neurology
doi 10.1001/archneurol.2009.50
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Medical Association (AMA)

Related search

Exercise and Disease Progression in Multiple Sclerosis: Can Exercise Slow Down the Progression of Multiple Sclerosis?

Therapeutic Advances in Neurological Disorders
NeurologyPharmacology
2011English

Multiple Sclerosis Disease Progression: Contributions From a Hypoxia–inflammation Cycle

Multiple Sclerosis
Neurology
2018English

Intrathecal Effects of Daclizumab Treatment of Multiple Sclerosis

Neurology
Neurology
2011English

The Efficacy and Safety of Daclizumab and Its Potential Role in the Treatment of Multiple Sclerosis

Therapeutic Advances in Neurological Disorders
NeurologyPharmacology
2013English

Lipoprotein Profiling in Early Multiple Sclerosis Patients: Effect of Chronic Inflammation?

Lipids in Health and Disease
BiochemistryEndocrinologyClinical BiochemistryMetabolismDiabetes
2020English

Smoking: Effects on Multiple Sclerosis Susceptibility and Disease Progression

Therapeutic Advances in Neurological Disorders
NeurologyPharmacology
2011English

Prevention of Autoimmune Attack and Disease Progression in Multiple Sclerosis: Current Therapies and Future Prospects

Internal Medicine Journal
Internal Medicine
2002English

Role of MRI in Multiple Sclerosis I: Inflammation and Lesions

Frontiers in Bioscience - Landmark
ImmunologyMolecular BiologyBiochemistryMicrobiology MedicineGenetics
2004English

Oxidative Stress and Inflammation Interdependence in Multiple Sclerosis

Journal of Clinical Medicine
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy